Genomic markers for ovarian cancer at chromosomes 1, 8 and 17 revealed by array CGH analysis

Tumori

Volumn 95, Issue 3, 2009, Pages 357-366

  Dimova, Ivanka ^a   Orsetti, Beatrice ^b   Negre, Vincent ^b   Rouge, Carole ^b   Ursule, Liza ^b   Lasorsa, Laurence ^b   Dimitrov, Rumen ^c   Doganov, Nikolai ^c   Toncheva, Draga ^a   Theillet, Charlles ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIV MONTPELLIER   (France)

^c University Hospital of Obstetrics and Gynecology 'Maichin Dom' Bulgaria   (Bulgaria)

Author keywords

Array CGH; Genomic instability; Oncogenes; Ovarian cancer

Indexed keywords

TUMOR MARKER;

ARTICLE; AXIN2 GENE; CANCER GENETICS; CANCER STAGING; CHROMOSOME 1; CHROMOSOME 17; CHROMOSOME 8; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; GENE AMPLIFICATION; GENETIC ASSOCIATION; GRB2 GENE; HISTOPATHOLOGY; HUMAN; LASP1 GENE; MARKER GENE; MUL GENE; ONCOGENE; OVARY CANCER; TBX2 GENE; TGF11 GENE;

ARRAY CGH; COMPARATIVE GENOMIC HYBRIDIZATIONS; GENOMIC INSTABILITY; HIGH RESOLUTION; HISTOLOGICAL TYPE; LITERATURE DATA; ONCOGENES; OVARIAN CANCERS;

DISEASES; HISTOLOGY; ONCOGENIC VIRUSES; TUMORS;

GENES;

EID: 67849106261     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160909500315     Document Type: Article

References (24)

1. Ilyas M, Straub J, Tomlinson IP, Bodmer WF: Genetic pathways in colorectal and other cancers. Eur J Cancer, 35: 335-351, 1999. (Pubitemid 30026220)
2. Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G: Genomic changes defining the genesis, progression, and malignant potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer, 25: 195-204, 1999. (Pubitemid 29266688)
3. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (Wash DC), 258: 818-821, 1992.
4. Bayani J, Brenton JD, Macgregor PF, Beheshti B, Albert M, Nallainathan D, Karaskova J, Rosen B, Murphy J, Laframboise S, Zanke B, Squire JA: Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays. Cancer Res, 62: 3466-3476, 2002.
5. Sonoda G, Palazzo J, du Manoir S, Godwin AK, Feder M, Yakushiji M, Testa JR: Comparative genomic hybridization detects frequent overexpression of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer, 20: 320-328, 1997.
6. Iwabuchi H, Sakamoto M, Sakunaga H, Ma YY, Carcangiu ML, Pinkel D, Yang-Feng TL, Gray JW: Genetic analysis of benign, low-grade and high-grade ovarian tumors. Cancer Res, 55: 6172-6180, 1995.
7. Suehiro Y, Sakamoto M, Umayahara K, Iwabuchi H, Sakamoto H, Tanaka N, Takeshima N, Yamauchi K, Hasumi K, Akiya T, Sakunaga H, Muroya T, Numa F, Kato H, Tenjin Y, Sugishita T: Genetic aberrations detected by comparative genomic hybridization in ovarian clear cell adenocarcinomas. Oncology, 59: 50-56, 2000. (Pubitemid 30435836)
8. Wolf NG, Abdul-Karim FW, Farver C, Schrock E, du Manoir S, Schwartz S: Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer, 25: 307-315, 1999.
9. Suzuki S, Moore DH 2nd, Ginzinger DG, Godfrey TE, Barclay J, Powell B, Pinkel D, Zaloudek C, Lu K, Mills G, Berchuck A, Gray JW : An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res, 60: 5382-5385, 2000.
10. Schraml P, Schwerdtfeger G, Burkhalter F, Raggi A, Schmidt D, Ruffalo T, King W, Wilber K, Mihatsch MJ, Moch H: Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol, 163: 985-992, 2003. (Pubitemid 37040134)
11. Hu J, Khanna V, Jones MM, Surti U: Genomic imbalances in ovarian borderline serous and mucinous tumors. Cancer Genet Cytogenet, 139: 18-23, 2002. (Pubitemid 36120401)
12. Hauptmann S, Denkert C, Koch I, Petersen S, Schluns K, Reles A, Dietel M, Petersen I: Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. Hum Pathol, 33: 632-641, 2002. (Pubitemid 34827545)
13. Fiegler H, Carr P, Douglas AJ, Burford DC, Hunt S, Scott CE, Smith J, Vetrie D, Gorman P, Tomlinson IP, Carter NP: DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer, 36: 361-374, 2003 (Pubitemid 36314519)
14. Albertson DG, Pinkel D: Genomic microarrays in human genetic disease and cancer. Hum Mol Genet, 12 (spec N2): R145-152, 2003.
15. Pollack J, Perou C, Alizadeh A, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, Brown PO: Genomewide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet, 23: 41-46, 1999. (Pubitemid 29418785)
16. Orsetti B, Nugoli M, Cervera N, Lasorsa L, Chuchana P, Ursule L, Nguyen C, Redon R, du Manoir S, Rodriguez C, Theillet C: Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes. Cancer Res, 64: 6453-6460, 2004.
17. Garcia A, Bussaglia E, Machin P, Matias-Guiu X, Prat J: Loss of heterozygosity on chromosome 17q in epithelial ovarian tumors: association with carcinomas with serous differentiation. Int J Gynecol Pathol, 19: 152-157, 2000. (Pubitemid 30212152)
18. Caduff RF, Svoboda-Newman SM, Bartos RE, Ferguson AW, Frank TS: Comparative analysis of histologic homologues of endometrial and ovarian carcinoma. Am J Surg Pathol, 22: 319-326, 1998.
19. Dion F, Mes-Masson AM, Seymour RJ, Provencher D, Tonin PN: Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers. Oncogene, 19: 1466-1472, 2000. (Pubitemid 30171178)
20. Taetle R, Aickin M, Jang JM, Panda L, Emerson J, Roe D, Adair L, Thompson F, Liu Y, Wisner L, Davis JR, Trent J, Alberts DS: Chromosome abnormalities in ovarian adenocarcinomas: I. Nonrandom chromosome abnormalities from 244 cases. Genes Chromosomes Cancer, 25: 290-300, 1999.
21. Lambros M, Fiegler H, Jones A, Gorman P, Roylance RR, Carter NP, Tomlinson IP: Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization. J Pathol, 205: 29-40, 2005. (Pubitemid 40029090)
22. Benetkiewicz M, Wang Y, Schaner M, Wang P, Mantripragada KK, Buckley PG, Kristensen G, Børresen-Dale AL, Dumanski JP: High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas. Genes Chromosomes Cancer, 42: 228-237, 2005.
23. Watanabe T, Imoto I, Kosugi Y, Ishiwata I, Inoue S, Takayama M, Sato A, Inazawa J: A novel amplification at 17q21-23 in ovarian cancer cell lines detected by comparative genomic hybridization. Gynecol Oncol, 81: 172-177, 2001.
24. Dimova I, Zaharieva B, Raitcheva S, Dimitrov R, Doganov N, Toncheva D: Tissue microarray analysis of Herl (EGFR) and Her2 (c-erbB-2) copy number changes in ovarian tumors. Int J Gynecol Cancer, 16: 145-151, 2006.